Introduction Increasing investment in eHealth aims to improve cost effectiveness and safety of care. Data extraction and aggregation can create new data products to improve professional practice and provide feedback to improve the quality of source data. A previous systematic review concluded that locally relevant clinical indicators and use of clinical record systems could support clinical governance. We aimed to extend and update the review with a theoretical framework. Methods We searched PubMed, Medline, Web of Science, ABI Inform (Proquest) and Business Source Premier (EBSCO) using the terms curation, information ecosystem, data quality management (DQM), data governance, information governance (IG) and data stewardship. We focused on and analysed the scope of DQM and IG processes, theoretical frameworks, and determinants of the processing, quality assurance, presentation and sharing of data across the enterprise. Findings There are good theoretical reasons for integrated governance, but there is variable alignment of DQM, IG and health system objectives across the health enterprise. Ethical constraints exist that require health information ecosystems to process data in ways that are aligned with improving health and system efficiency and ensuring patient safety. Despite an increasingly 'big-data' environment, DQM and IG in health services are still fragmented across the data production cycle. We extend current work on DQM and IG with a theoretical framework for integrated IG across the data cycle. Conclusions The dimensions of this theory-based framework would require testing with qualitative and quantitative studies to examine the applicability and utility, along with an evaluation of its impact on data quality across the health enterprise.
INTRODUCTION
There has been significant investment in eHealth 1 and new forms of research taking advantage of information technology, so-called eResearch. 2 This has come about as a result of health reform emphasising the need for more efficient integrated care underpinned by electronic health records (EHRs) and clinical information systems (CISs) to monitor and improve the safety and quality of patient care in ways which paper records cannot. Increasingly, data contained in single EHRs/CISs (or data repositories with data from multiple EHRs/CISs) are being used as major sources of information to create knowledge about health practice, both overseas 3 and in Australia. 4 Indeed, it has been suggested that systematic interrogation of large high-quality social media datasets 5, 6 or CIS 7 may well replace current scientific research methods to create knowledge such as randomised controlled trials.
We increasingly work within an information ecosystem, where secondary processors of data may take us beyond the current data paradigms and ensure that semantically integrated data within a health system are of sufficient quality. For example, the Australian national eHealth record system, including the personally controlled EHR (PCEHR), will require semantically interoperable data aggregated from disparate organisational EHR/CIS. Data and information governance, along with knowledge management, is critical to ensure that the integrity of health data and information is maintained to ensure their fitness for purpose. However, whilst information governance (IG) is mostly in place, data quality (DQ) is left as a side issue. Good data quality management (DQM) and IG, embedded in good corporate and clinical governance, is therefore an unrealised priority. The burgeoning numbers of health data repositories and increasing volumes of health data within them make it timely to align good DQM and IG with the objectives of the health organisation, establishing roles and responsibilities to ensure high-quality data to support the delivery of safe and effective patient care and monitoring the impact, quality and safety of the care.
This article builds on a recent systematic review, which concluded that locally relevant clinical indicators and the use of EHRs could support clinical governance 8 and a previous review of DQ and DQM. 9 These and related studies and reviews suggested the need for good data and information governance and quality management in organisations that routinely collect data in EHRs, along with a robust theoretical framework. This article describes the development of the theoretical framework within the framework of clinical and corporate management and governance.
Box 1 Definitions of key terms
Curation: The activity of managing and promoting the use of data from their point of creation, to ensure they are fit for contemporary purpose, and available for discovery and reuse. 9 using these two reviews as starting points with a view to incorporating IG.
The search was theory driven and conducted iteratively, including only papers with an emphasis on theory or conceptual frameworks. We analysed the scope of DQM and IG processes in the health information ecosystem, theoretical frameworks and determinants of the processing, quality assurance, presentation and sharing of high-quality data across the enterprise to ensure the information is fit for care monitoring, coordination and improvement.
Health, data and technical perspectives must be combined to ensure that health data products are fit for purpose. This approach is consistent with the International Standards Organisation (ISO) definition of quality as the totality of features and characteristics of an entity that bears on its ability to satisfy stated and implied needs (ISO 8402-1986, Quality Vocabulary).
The quality of routinely collected data is affected by errors of omission and commission at many points described by a conceptual framework ( Figure 1 ) to assess the fitness of routinely collected data for research, audit and quality assurance purposes. 10 Mapping the DQM and IG processes within this framework requires a formal system of metadata, covering both primary and secondary variables. Outputs from routinely collected datasets should include information on data provenance and processing methods across the data cycle.
10 DQM and IG must address data creation and capture/collection and proceed through the data cycle to data curation, presentation of the data product and user guidance and support. The ISO 9000 series of quality standards emphasises the prevention of defects through the planning and application of best practices at every stage of the business -from design through to installation and servicing (http://www.isocenter. com/9000/WHATIS.html).
The health objective is safe and effective care of the patient and population groups and the collection of good quality data to describe the process and content of health care provided. The data cycle begins with the creation and collection of data as part of clinician-patient interaction within the confidential therapeutic relationship. The technical and business objectives are to ensure that corporate data are good enough to support the health objective. Good corporate and clinical governance requires good IG across the DQ cycle to ensure that the organisational environment, information and culture supports and facilitates the achievement of the health objective and collection of good data at point of care. Approaches and mechanisms to achieve this must be flexible as they will vary according to the sector, institution or other contextual constraints. 20 health data and information can be conceptualised as a product of a communicative action by a health professional interacting and making and acting on decisions with a patient in a Habermasian lifeworld (Box 2). The presence (or absence) of data and information provided by patients and filtered by clinicians is captured in the database schemas and metadata rules in the CIS, a part of the 'system' where 'strategic action' takes place. The information, which may be rich narratives or presence/absence of standard terms, can then be translated into formats that can be used for other purposes such as decision support, quality improvement and research. 
Lifeworld:
The stock of experiences and competencies used to negotiate the world.
The interpretive schemes of Giddens' structuration theory, 21 which describes the transition of information between structure and communication, further explain the capture of communicative actions, making them and their products available to the system. Data and information are vehicles by which the process and effects of human interaction and communicative action are placed in a system construct and captured in a CIS, where it can shape an organisation/system and associated processes and protocols. This host-guest relationship 19 at the data level emphasises that data are not only the product of an interaction for consumption by clinicians, researchers or policy makers but are also agents within the care process, influencing the cycle of care and promoting continuous quality improvement within an informational space and ecosystem. 22 Pór described the knowledge ecosystem as a 'triple network' that comprises (i) a people network of productive conversations, (ii) a knowledge network of ideas, information and inspiration, supported by (iii) a technology network of knowledge bases and communication links to nurture collective intelligence and systemic wisdom.
23
This multilevel conceptual framework with people, technology and data and knowledge dimensions facilitates the understanding of actions on the data as well as the use of data to achieve organisational and system objectives. Data are not just a technical creation, but are also a social construct for personal, professional and organisational purposes. This should guide directors and senior management of organisations to structure the IG and DQM roles, responsibilities and accountabilities of staff, develop processes, and understand technology and social requirements to support decision-making processes and authority for data-related matters in the 'lifeworld'.
FINDINGS AND PROPOSITION
Combining this trans-theoretical framework with our experience with General Practice Networks and Medicare Locals in Australia 24 and Clinical Commissioning Groups in England, 25 we emphasise the need for alignment and integration across the data production cycle and propose three models of health care organisations, which may explain their affinity to adopt integrated DQM and IG: 26 1. The corporate model, in which patients are clients or customers, and the primary concern of the organisation is economic. 2. The organisation as an orchestrator of providers which, like an airport that organises airlines and passengers, devolves some responsibility to the health care providers. 3. The organisation as a community of practice. The IG structures, ethical frameworks and DQM methods will vary with function; size, from organisation-based 'small data' to large national 'big-data' repositories; and whether the use of data is primary (e.g. for clinical care) or secondary. We believe this primary/secondary distinction to be artificial and, building on existing work, 24 propose a hierarchy of use of data and information (Box 3). All uses are important, but need to be prioritised to create 'fit for purpose' data.
The need for alignment and integration across the data cycle
There is little focus on the data creator or collector beyond general statements to ensure that information collected and created is appropriate to business needs. This increasing isolation of data managers from data creators and collectors, who are usually clinicians and scientists, is consistent with our own experience in Australia and England and has major impacts on the quality of routinely collected data in both hospital 27 and general practice 28 settings. We lack a support system and professional culture that value strategies to support busy clinicians to collect and create comprehensive and consistent health data for use in decision support systems, to conduct population health research or monitor safety and quality of care. By understanding the 'lifeworld' as source and the 'sociotechnical system' as interpreter within a realist and phenomenological enquiry framework, we can conceptualise a theory-driven approach to align DQM, IG and organisational objectives. DQM, IG and the objectives of the health organisation or system must be aligned logically and operationalised within the information ecosystem of the organisation and system (Figure 2 ).
At the corporate governance level, if the IG is good but DQM is poor, we cannot make good decisions because we do not know how good the data are. If the DQM is good but the IG is poor, the organisation is not well governed as the clinical and corporate governors cannot make good decisions and manage the risks to the organisation. At the operational level, a mal-aligned and unaligned DQM and IG structure and process within the information ecosystem means that there are data in the system but we do not know whether they are fit for purpose or have great difficulty accessing the (Figure 2 ). The optimum situation is to nest DQM and organisational objectives within the information ecosystem, which is governed by an IG framework overseen by an IG authority. Our experience is that most organisations are partially aligned or mal-aligned in Australia 8, 27 and England 29 where IG policy is technology focused with some professional responsibilities, and DQM initiatives happening elsewhere in the organisation or driven by the use of data for pay-for-performance 30 or other quality initiatives or technical developments such as a unique English National Health Service identifier and laboratory links.
CONCLUSION
We have extended the current work on DQM and IG with a unifying theoretical framework. The phenomenological and realist analytic lens of the framework emphasises human agency and reasoning from both cognitive and affective perspectives, applicable to both patient and clinician. There are good theoretical reasons for aligned and integrated DQM and IG across the enterprise to achieve optimal data utility and quality. Regulatory bodies should require service providers to see their IG responsibilities as making high-quality data available to their health ecosystem partners to monitor delivery of health system objectives and to further improve DQ across the health enterprise and across the data production cycle from data creation and collection to data management, curation and use. The dimensions of this theoretical framework would require testing with qualitative and quantitative studies to examine the applicability and utility, along with an evaluation of its impact.
